On February 27, 2026, the EMA’s Committee for Medicinal Products for Human Use recommended acoziborole for treating early and ...
A single-dose pill called acoziborole cured most sleeping sickness patients in a major trial, even when the parasite reached the brain.
A new drug may help treat and eventually eliminate sleeping sickness by improving adherence and accessibility to treatment.